Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Updated location label from Napoli, Italy, 80131 to Naples, Italy, 80131 in the study locations.
    Difference
    0.1%
    Check dated 2026-03-25T21:18:01.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site’s revision history now shows Revision: v3.5.0 added and Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:10:23.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed on the page, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:19:54.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-status notice was removed, representing a minor site maintenance update that does not affect the trial details or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T06:24:25.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a site-wide Notice about a lapse in government funding with directions to cc.nih.gov and opm.gov. Updated the page to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:42.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Minor editorial updates include capitalization tweaks for QC terminology, a new 'Show glossary' option, and a revision tag (v3.4.0) replacing the previous version.
    Difference
    0.2%
    Check dated 2026-01-28T03:30:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.